China TCM names Guo Jinhong chairman as Yang Jun retires

• China Traditional Chinese Medicine Holdings named Guo Jinhong executive director, chairman, and authorized representative, effective July 17, 2026.
• Guo was elected chair of the nomination committee and strategic committee on the same date.
• Yang Jun stepped down as executive director and board chairman on reaching statutory retirement age, effective immediately.
• Guo previously worked at China’s National Audit Office and led audit and supervision at CRCC Capital Holdings Group.
• He joined China National Pharmaceutical Group in 2022, later running audit and compliance functions, and has been Sinopharm Group supervisor since 2023.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Traditional Chinese Medicine Holdings Co. Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260717-12248758), on July 17, 2026, and is solely responsible for the information contained therein.